-
EP4087860
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4087860
| EP4087860 - COMPOUND AND METHOD FOR TREATMENT OF ALZHEIMER'S DISEASE [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 20.10.2023 Database last updated on 15.06.2024 | |
| Former | Grant of patent is intended Status updated on 25.06.2023 | ||
| Former | Request for examination was made Status updated on 14.10.2022 | ||
| Former | The international publication has been made Status updated on 16.07.2021 | ||
| Former | unknown Status updated on 26.01.2021 | Most recent event Tooltip | 31.05.2024 | Lapse of the patent in a contracting state New state(s): ES, HR, NO, PL, RS | published on 03.07.2024 [2024/27] | Applicant(s) | For all designated states Alphabeta AB C/o Monika Hagman Sveavägen 18 A 182 60 Djursholm / SE | [2022/46] | Inventor(s) | 01 /
JOHANSSON, Jan c/o Alphabeta AB KI-ADRC, NVS Dept., Karolinska Institutet, Novum, plan 5 141 86 Stockholm / SE | [2022/46] | Representative(s) | AWA Sweden AB Box 45086 104 30 Stockholm / SE | [2022/46] | Application number, filing date | 21700377.1 | 07.01.2021 | [2022/46] | WO2021EP50168 | Priority number, date | EP20200150738 | 08.01.2020 Original published format: EP 20150738 | [2022/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021140140 | Date: | 15.07.2021 | Language: | EN | [2021/28] | Type: | A1 Application with search report | No.: | EP4087860 | Date: | 16.11.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.07.2021 takes the place of the publication of the European patent application. | [2022/46] | Type: | B1 Patent specification | No.: | EP4087860 | Date: | 22.11.2023 | Language: | EN | [2023/47] | Search report(s) | International search report - published on: | EP | 15.07.2021 | Classification | IPC: | C07K14/435, A61K38/17 | [2022/46] | CPC: |
C07K14/435 (EP);
C07K14/47 (US);
A61P25/28 (US);
A61K38/00 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/46]
| Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VERBINDUNGEN UND VERFAHREN ZUR BEHANDLUNG VON MORBUS ALZHEIMER | [2022/46] | English: | COMPOUND AND METHOD FOR TREATMENT OF ALZHEIMER'S DISEASE | [2022/46] | French: | COMPOSÉ ET PROCÉDÉ POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER | [2023/28] |
| Former [2022/46] | COMPOSÉ ET PROCÉDÉ DE TRAITEMENT DE LA MALADIE D'ALZHEIMER | Entry into regional phase | 08.08.2022 | National basic fee paid | 08.08.2022 | Designation fee(s) paid | 08.08.2022 | Examination fee paid | Examination procedure | 08.08.2022 | Amendment by applicant (claims and/or description) | 08.08.2022 | Examination requested [2022/46] | 08.08.2022 | Date on which the examining division has become responsible | 26.06.2023 | Communication of intention to grant the patent | 17.10.2023 | Fee for grant paid | 17.10.2023 | Fee for publishing/printing paid | 17.10.2023 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 30.12.2022 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | ES | 22.11.2023 | HR | 22.11.2023 | PL | 22.11.2023 | RS | 22.11.2023 | NO | 22.02.2024 | GR | 23.02.2024 | IS | 22.03.2024 | [2024/27] |
| Former [2024/20] | GR | 23.02.2024 | |
| IS | 22.03.2024 | Cited in | International search | [AD]WO2012138284 (ALPHABETA AB [SE], et al) [AD] 1-19* figure 2 *; | [A] - Wei, Q., ""Draft Genome and Complete Hox-Cluster Characterization of the SterletRT Sturgeon (Acipenser ruthenus)."", UniProt, (20190508), Database accession no. A0A444U9X2, XP002798719 [A] 1-19 * the whole document * | [A] - Ncbi, "integral membrane protein 2B [Erpetoichthys calabaricus]", Protein, (20190421), Database accession no. XP_028655526, URL: NCBI, XP002798720 [A] 1-19 * the whole document * | [A] - SANCHEZ-PULIDO L ET AL, "BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer", TRENDS IN BIOCHEMICAL SCIENCES, ELSEVIER, AMSTERDAM, NL, (20020701), vol. 27, no. 7, doi:10.1016/S0968-0004(02)02134-5, ISSN 0968-0004, pages 329 - 332, XP004369724 [A] 1-19 * figure 1 * DOI: http://dx.doi.org/10.1016/S0968-0004(02)02134-5 | by applicant | WO2011162655 | WO2012138284 | - SANCHEZ-PULIDO et al., Trends Biochem Sci, (20020000), vol. 27, no. 7, pages 329 - 332 | - CHEN et al., Nat. Commun., (20170000), vol. 8, page 2081 | - THOMPSON, J.D.HIGGINS, D.G.GIBSON, T.J., Nucleic Acids Research, (19940000), vol. 22, pages 4673 - 4680 | - STURCHLER-PIERRAT et al., Rev Neurosci, (19990000), vol. 10, pages 15 - 24 | - SEABROOK, Neuropharmacol, (19990000), vol. 38, pages 1 - 17 | - DEARMOND, Brain Pathology, (19950000), vol. 5, pages 77 - 89 | - TELLING, Neuropathol Appl Neurobiol, (20000000), vol. 26, pages 209 - 220 | - PRICE et al., Science, (19980000), vol. 282, pages 1079 - 1083 | - SAITO et al., Nature Neuroscience, (20140000), vol. 17, no. 5, pages 661 - 663 | - CHEN et al., Nat Commun, (20170000), vol. 8, page 2081 | - TAMBARO et al., J Biol Chem., (20190000), vol. 294, pages 2606 - 2615 | - CHEN et al., Commun Biol, (20200000), vol. 3, page 32 |